COVID-19 and hydroxychloroquine side-effects: glucose 6-phosphate dehydrogenase deficiency (G6PD) and acute haemolytic anaemia.
作者信息
Chaney S, Basirat A, McDermott R, Keenan N, Moloney E
机构信息
From the Respiratory Department, Tallaght University Hospital at Tallaght, Dublin 24, D24 NR0A.
出版信息
QJM. 2020 Dec 1;113(12):890-891. doi: 10.1093/qjmed/hcaa267.
Abstract
摘要
相似文献
1
COVID-19 and hydroxychloroquine side-effects: glucose 6-phosphate dehydrogenase deficiency (G6PD) and acute haemolytic anaemia.
QJM. 2020 Dec 1;113(12):890-891. doi: 10.1093/qjmed/hcaa267.
2
COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.
Eur J Haematol. 2020 Sep;105(3):357-359. doi: 10.1111/ejh.13432. Epub 2020 May 7.
3
Hemolytic Anemia in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient Receiving Hydroxychloroquine for COVID-19: A Case Report.
Perm J. 2020;24. doi: 10.7812/TPP/20.158.
4
A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
Infect Dis (Lond). 2020 Sep;52(9):659-661. doi: 10.1080/23744235.2020.1774644. Epub 2020 Jun 4.
5
Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.
Emerg Infect Dis. 2020 Sep;26(9):2279-81. doi: 10.3201/eid2609.202353. Epub 2020 Jun 24.
6
A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
Am J Case Rep. 2020 Jul 22;21:e925788. doi: 10.12659/AJCR.925788.
7
Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a "humanized" G6PD A- mouse model.
PLoS One. 2020 Oct 2;15(10):e0240266. doi: 10.1371/journal.pone.0240266. eCollection 2020.
8
Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine.
Am J Hematol. 2020 Aug;95(8):E194-E196. doi: 10.1002/ajh.25862. Epub 2020 Jun 18.
9
Typhoid fever and haemolytic anaemia in a black patient with glucose-6-phosphate dehydrogenase deficiency. A case report.
S Afr Med J. 1985 Jul 20;68(2):110-1.
10
Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out.
Eur J Intern Med. 2020 Oct;80:103. doi: 10.1016/j.ejim.2020.08.015. Epub 2020 Aug 13.
引用本文的文献
1
Associations between COVID-19 and Glucose-6-Phosphate Dehydrogenase Activity in Brazil.
Am J Trop Med Hyg. 2024 Apr 9;110(6):1191-1197. doi: 10.4269/ajtmh.23-0148. Print 2024 Jun 5.
2
Hematologic Outcomes of COVID-19 Patients with and without G6PD Deficiency: A Comparative Study.
Qatar Med J. 2022 Nov 16;2022(4):54. doi: 10.5339/qmj.2022.54. eCollection 2022.
3
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.
Pharmaceuticals (Basel). 2022 May 21;15(5):634. doi: 10.3390/ph15050634.
4
Occurrence of Methemoglobinemia due to COVID-19: A Case Report.
Cureus. 2022 Mar 14;14(3):e23155. doi: 10.7759/cureus.23155. eCollection 2022 Mar.
5
Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives.
Trends Pharmacol Sci. 2021 Oct;42(10):829-844. doi: 10.1016/j.tips.2021.07.002. Epub 2021 Aug 10.
6
Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review.
Mol Biol Rep. 2021 Mar;48(3):2973-2978. doi: 10.1007/s11033-021-06234-y. Epub 2021 Feb 23.
7
The Role of Methemoglobin and Carboxyhemoglobin in COVID-19: A Review.
J Clin Med. 2020 Dec 25;10(1):50. doi: 10.3390/jcm10010050.
Zotero 插件